Author

Konrad Aden 1

1 Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein,Kiel,Germany;1st Department of Medicine,University Hospital Schleswig-Holstein,Kiel,Germany

AN INTERPLAY BETWEEN AUTOPHAGY AND ER STRESS COORDINATES INTERLEUKIN-22 DEPENDENT SIGNALS IN THE INTESTINAL EPITHELIUM

Konrad Aden, Florian Tran, Maren Falk-Paulsen, Anne Luzius, Jan Kuiper, Robert Häsler, Raheleh Sheibani-Tezerji, Stefan Schreiber, Richard Steven Blumberg, Arthur Kaser, Philip Rosenstiel

AN INTERPLAY BETWEEN AUTOPHAGY AND ER STRESS COORDINATES INTERLEUKIN-22 DEPENDENT SIGNALS IN THE INTESTINAL EPITHELIUM

Konrad Aden

ANTI TNFA THERAPY MODULATES THE INTESTINAL MICROBIOTA ACROSS CHRONIC INFLAMMATORY DISEASE

Konrad Aden, ateequr rehmann, Wei-Hung Pang, Johannes Bethge, Susanna Nikolaus, rainald zeuner, Johann Oltmann Schroeder, Stefan Schreiber, Philip Rosenstiel

Atg16l1 coordinates DNA damage response in the intestinal epithelium

Nassim Kakavand, Lina Welz, Joana Pimenta Bernardes, Felix Wottawa, Jacob Hamm, Florian Tran, Stefan Schreiber, Konrad Aden, Philip Rosenstiel

CONFOCAL LASER ENDOMICROSCOPY REVEALS DIFFERENTIAL RESPONSE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS UNDERGOING ANTI-INTEGRIN COMPARED TO ANTI-TNF-ALPHA THERAPY

Mark Ellrichmann, Johannes Bethge, Golo Aust, Berenice Schulte, Susanna Nikolaus, Konrad Aden, Stefan Schreiber

Early dynamics of peripheral blood gene expression and DNA methylation predict response to anti-TNFa therapy in a prospective multi-OMICS analysis in IBD patients

Neha Mishra, Konrad Aden, Johanna Ira Blase, Claudio Conrad, Susanna Nikolaus, Guillaume Rey, Manolis Dermitzakis, Stefan Schreiber, Philip Rosenstiel

EPITHELIAL IL-23R SIGNALING LICENSES PROTECTIVE IL-22 RESPONSES IN INTESTINAL INFLAMMATION

Konrad Aden, Ateequr Rehman, Simone Lipinski, Maren Paulsen, Arthur Kaser, Stefan Schreiber, Philip Rosenstiel

EPITHELIAL IL-23R SIGNALING LICENSES PROTECTIVE IL-22 RESPONSES IN INTESTINAL INFLAMMATION

Konrad Aden

Gut microbial metabolic functions are associated with Anti-TNF efficacy in IBD patients

Konrad Aden, Ateequr Rehman, Silvio Waschina, Alesia Walker, Alejandro Nunez, Johannes Zimmermann, Andre Franke, Susanna Nikolaus, Doris Vandeputte, Jeroen Raes, Philippe Schmitt-Kopplin, Christoph Kaleta, Stefan Schreiber, Philip Rosenstiel

INTERLEUKIN-6 TRANS-SIGNALLING INHIBITION WITH OLAMKICEPT (sgp130Fc) IN ACTIVE IBD RESULTS IN EARLY UNIQUE MOLECULAR SIGNATURES PREDICTING CLINICAL REMISSION AND DIFFERENTIATING FROM REMISSION INDUCTION BY VEDOLIZUMAB OR INFLIXIMAB

Konrad Aden, Claudio Conrad, Joana Pimenta Bernardes, Florian Tran, Hanna Hoeper, Felix Sommer, Susanna Nikolaus, Juliane Lokau, Christoph Garbers, Stefan Rose-John, Christoph Röcken, Georg H Waetzig, Philip Rosenstiel, Stefan Schreiber

Item 1 - 10 / 19
1
2